168 related articles for article (PubMed ID: 22963631)
1. Antiviral properties against HIV of water soluble copper carbosilane dendrimers and their EPR characterization.
Galan M; Sanchez-Rodriguez J; Cangiotti M; Garcia-Gallego S; Jimenez JL; Gomez R; Ottaviani MF; Munoz-Fernandez MA; de la Mata FJ
Curr Med Chem; 2012; 19(29):4984-94. PubMed ID: 22963631
[TBL] [Abstract][Full Text] [Related]
2. Carbosilane metallodendrimers based on copper (II) complexes: Synthesis, EPR characterization and anticancer activity.
Sanz Del Olmo N; Maroto-Díaz M; Gómez R; Ortega P; Cangiotti M; Ottaviani MF; de la Mata FJ
J Inorg Biochem; 2017 Dec; 177():211-218. PubMed ID: 29031179
[TBL] [Abstract][Full Text] [Related]
3. New anionic carbosilane dendrons functionalized with a DO3A ligand at the focal point for the prevention of HIV-1 infection.
Moreno S; Sepúlveda-Crespo D; de la Mata FJ; Gómez R; Muñoz-Fernández MÁ
Antiviral Res; 2017 Oct; 146():54-64. PubMed ID: 28827122
[TBL] [Abstract][Full Text] [Related]
4. Anionic Carbosilane Dendrimers Destabilize the GP120-CD4 Complex Blocking HIV-1 Entry and Cell to Cell Fusion.
Guerrero-Beltran C; Rodriguez-Izquierdo I; Serramia MJ; Araya-Durán I; Márquez-Miranda V; Gomez R; de la Mata FJ; Leal M; González-Nilo F; Muñoz-Fernández MA
Bioconjug Chem; 2018 May; 29(5):1584-1594. PubMed ID: 29570280
[TBL] [Abstract][Full Text] [Related]
5. Synergistic activity profile of carbosilane dendrimer G2-STE16 in combination with other dendrimers and antiretrovirals as topical anti-HIV-1 microbicide.
Sepúlveda-Crespo D; Lorente R; Leal M; Gómez R; De la Mata FJ; Jiménez JL; Muñoz-Fernández MÁ
Nanomedicine; 2014 Apr; 10(3):609-18. PubMed ID: 24135563
[TBL] [Abstract][Full Text] [Related]
6. Anionic sulfonated and carboxylated PPI dendrimers with the EDA core: synthesis and characterization of selective metal complexing agents.
García-Gallego S; Cangiotti M; Fiorani L; Fattori A; Muñoz-Fernández MÁ; Gomez R; Ottaviani MF; de la Mata FJ
Dalton Trans; 2013 Apr; 42(16):5874-89. PubMed ID: 23462972
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of new anionic carbosilane dendrimers via thiol-ene chemistry and their antiviral behaviour.
Galán M; Sánchez Rodríguez J; Jiménez JL; Relloso M; Maly M; de la Mata FJ; Muñoz-Fernández MA; Gómez R
Org Biomol Chem; 2014 May; 12(20):3222-37. PubMed ID: 24728319
[TBL] [Abstract][Full Text] [Related]
8. Novel 'Si-C' carbosilane dendrimers as carriers for anti-HIV nucleic acids: studies on complexation and interaction with blood cells.
Pedziwiatr-Werbicka E; Fuentes E; Dzmitruk V; Sánchez-Nieves J; Sudas M; Drozd E; Shakhbazau A; Shcharbin D; de la Mata FJ; Gomez-Ramirez R; Munoz-Fernandez MA; Bryszewska M
Colloids Surf B Biointerfaces; 2013 Sep; 109():183-9. PubMed ID: 23643914
[TBL] [Abstract][Full Text] [Related]
9. Dendronized Anionic Gold Nanoparticles: Synthesis, Characterization, and Antiviral Activity.
Peña-González CE; García-Broncano P; Ottaviani MF; Cangiotti M; Fattori A; Hierro-Oliva M; González-Martín ML; Pérez-Serrano J; Gómez R; Muñoz-Fernández MÁ; Sánchez-Nieves J; de la Mata FJ
Chemistry; 2016 Feb; 22(9):2987-99. PubMed ID: 26875938
[TBL] [Abstract][Full Text] [Related]
10. Development of water-soluble polyanionic carbosilane dendrimers as novel and highly potent topical anti-HIV-2 microbicides.
Briz V; Sepúlveda-Crespo D; Diniz AR; Borrego P; Rodes B; de la Mata FJ; Gómez R; Taveira N; Muñoz-Fernández MÁ
Nanoscale; 2015 Sep; 7(35):14669-83. PubMed ID: 26274532
[TBL] [Abstract][Full Text] [Related]
11. G2-S16 sulfonate dendrimer as new therapy for treatment failure in HIV-1 entry inhibitors.
Rodríguez-Izquierdo I; Natalia C; García F; Los Ángeles Muñoz-Fernandez M
Nanomedicine (Lond); 2019 May; 14(9):1095-1107. PubMed ID: 31066644
[No Abstract] [Full Text] [Related]
12. Elaborated study of Cu(II) carbosilane metallodendrimers bearing substituted iminopyridine moieties as antitumor agents.
Carloni R; Sanz Del Olmo N; Canonico B; Montanari M; Ciacci C; Ambrosi G; de la Mata FJ; Ottaviani MF; García-Gallego S
Eur J Med Chem; 2021 Apr; 215():113292. PubMed ID: 33631696
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of carbosilane dendrimers with an antiretroviral combination against HIV-1 in the presence of semen-derived enhancer of viral infection.
García-Broncano P; Ceña-Diez R; de la Mata FJ; Gómez R; Resino S; Muñoz-Fernández MÁ
Eur J Pharmacol; 2017 Sep; 811():155-163. PubMed ID: 28577966
[TBL] [Abstract][Full Text] [Related]
14. Antiviral mechanism of polyanionic carbosilane dendrimers against HIV-1.
Vacas-Córdoba E; Maly M; De la Mata FJ; Gómez R; Pion M; Muñoz-Fernández MÁ
Int J Nanomedicine; 2016; 11():1281-94. PubMed ID: 27103798
[TBL] [Abstract][Full Text] [Related]
15. Enhanced activity of carbosilane dendrimers against HIV when combined with reverse transcriptase inhibitor drugs: searching for more potent microbicides.
Vacas-Córdoba E; Galán M; de la Mata FJ; Gómez R; Pion M; Muñoz-Fernández MÁ
Int J Nanomedicine; 2014; 9():3591-600. PubMed ID: 25114528
[TBL] [Abstract][Full Text] [Related]
16. Fine-Tuning the Interaction and Therapeutic Effect of Cu(II) Carbosilane Metallodendrimers in Cancer Cells: An
Canonico B; Carloni R; Sanz Del Olmo N; Papa S; Nasoni MG; Fattori A; Cangiotti M; de la Mata FJ; Ottaviani MF; García-Gallego S
Mol Pharm; 2020 Jul; 17(7):2691-2702. PubMed ID: 32484691
[TBL] [Abstract][Full Text] [Related]
17. Novel Water-Soluble Mucoadhesive Carbosilane Dendrimers for Ocular Administration.
Bravo-Osuna I; Vicario-de-la-Torre M; Andrés-Guerrero V; Sánchez-Nieves J; Guzmán-Navarro M; de la Mata FJ; Gómez R; de Las Heras B; Argüeso P; Ponchel G; Herrero-Vanrell R; Molina-Martínez IT
Mol Pharm; 2016 Sep; 13(9):2966-76. PubMed ID: 27149661
[TBL] [Abstract][Full Text] [Related]
18. Sialyl alpha(2-->3) lactose clusters using carbosilane dendrimer core scaffolds as influenza hemagglutinin blockers.
Oka H; Onaga T; Koyama T; Guo CT; Suzuki Y; Esumi Y; Hatano K; Terunuma D; Matsuoka K
Bioorg Med Chem Lett; 2008 Aug; 18(15):4405-8. PubMed ID: 18639456
[TBL] [Abstract][Full Text] [Related]
19. Nanotechnology against human cytomegalovirus in vitro: polyanionic carbosilane dendrimers as antiviral agents.
Relaño-Rodríguez I; Espinar-Buitrago MS; Martín-Cañadilla V; Gómez-Ramirez R; Jiménez JL; Muñoz-Fernández MA
J Nanobiotechnology; 2021 Mar; 19(1):65. PubMed ID: 33658029
[TBL] [Abstract][Full Text] [Related]
20. Polyanionic carbosilane dendrimers as a new adjuvant in combination with latency reversal agents for HIV treatment.
Relaño-Rodríguez I; Juárez-Sánchez R; Pavicic C; Muñoz E; Muñoz-Fernández MÁ
J Nanobiotechnology; 2019 May; 17(1):69. PubMed ID: 31113488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
